These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 10343140)

  • 1. Sequential treatment of anemia in ulcerative colitis with intravenous iron and erythropoietin.
    Gasche C; Dejaco C; Reinisch W; Tillinger W; Waldhoer T; Fueger GF; Lochs H; Gangl A
    Digestion; 1999; 60(3):262-7. PubMed ID: 10343140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evaluation of the efficacy of intravenous iron III-hydroxide saccharate for treating adult patients with iron deficiency anemia].
    Cançado RD; Brasil SA; Noronha TG; Chiattone CS
    Rev Assoc Med Bras (1992); 2005; 51(6):323-8. PubMed ID: 16444338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous iron and erythropoietin for anemia associated with Crohn disease. A randomized, controlled trial.
    Gasché C; Dejaco C; Waldhoer T; Tillinger W; Reinisch W; Fueger GF; Gangl A; Lochs H
    Ann Intern Med; 1997 May; 126(10):782-7. PubMed ID: 9148651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iron sucrose with and without recombinant erythropoietin for the treatment of severe postpartum anemia: a prospective, randomized, open-label study.
    Krafft A; Breymann C
    J Obstet Gynaecol Res; 2011 Feb; 37(2):119-24. PubMed ID: 21159035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative study--efficacy, safety and compliance of intravenous iron sucrose and intramuscular iron sorbitol in iron deficiency anemia of pregnancy.
    Wali A; Mushtaq A; Nilofer
    J Pak Med Assoc; 2002 Sep; 52(9):392-5. PubMed ID: 12532571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of intravenously administered iron sucrose with and without adjuvant recombinant human erythropoietin for the treatment of resistant iron-deficiency anemia during pregnancy.
    Breymann C; Visca E; Huch R; Huch A
    Am J Obstet Gynecol; 2001 Mar; 184(4):662-7. PubMed ID: 11262469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pediatric Crohn's disease, iron deficiency anemia and intravenous iron treatment: a follow-up study.
    Valério de Azevedo S; Maltez C; Lopes AI
    Scand J Gastroenterol; 2017 Jan; 52(1):29-33. PubMed ID: 27576956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral and intravenous iron treatment in inflammatory bowel disease: hematological response and quality of life improvement.
    Gisbert JP; Bermejo F; Pajares R; Pérez-Calle JL; Rodríguez M; Algaba A; Mancenido N; de la Morena F; Carneros JA; McNicholl AG; González-Lama Y; Maté J
    Inflamm Bowel Dis; 2009 Oct; 15(10):1485-91. PubMed ID: 19408339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of Total Dose Infusion of Iron Intravenously in Patients With Acute Heart Failure and Anemia (Hemoglobin < 13 g/dl).
    Kaminsky BM; Pogue KT; Hanigan S; Koelling TM; Dorsch MP
    Am J Cardiol; 2016 Jun; 117(12):1942-6. PubMed ID: 27161817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid recurrence of IBD-associated anemia and iron deficiency after intravenous iron sucrose and erythropoietin treatment.
    Kulnigg S; Teischinger L; Dejaco C; Waldhör T; Gasche C
    Am J Gastroenterol; 2009 Jun; 104(6):1460-7. PubMed ID: 19491860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improvement of anemia with erythropoietin and intravenous iron reduces sleep-related breathing disorders and improves daytime sleepiness in anemic patients with congestive heart failure.
    Zilberman M; Silverberg DS; Bits I; Steinbruch S; Wexler D; Sheps D; Schwartz D; Oksenberg A
    Am Heart J; 2007 Nov; 154(5):870-6. PubMed ID: 17967592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimizing preoperative haemoglobin in major orthopaedic surgery using intravenous iron with or without erythropoietin. An epidemiologic study.
    Basora M; Colomina MJ; Tio M; Mora L; Sánchez-Etayo G; Salazar F; Ciércoles E; Paños M; Guerrero E; Berge R
    Rev Esp Anestesiol Reanim; 2015; 62(6):313-21. PubMed ID: 25698609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tolerance and efficacy of intravenous iron saccharate for iron deficiency anemia in children and adolescents receiving long-term parenteral nutrition.
    Michaud L; Guimber D; Mention K; Neuville S; Froger H; Gottrand F; Turck D
    Clin Nutr; 2002 Oct; 21(5):403-7. PubMed ID: 12381338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early prediction of response to intravenous iron supplementation by reticulocyte haemoglobin content and high-fluorescence reticulocyte count in haemodialysis patients.
    Chuang CL; Liu RS; Wei YH; Huang TP; Tarng DC
    Nephrol Dial Transplant; 2003 Feb; 18(2):370-7. PubMed ID: 12543894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized Open-Label Phase 1 Study of the Pharmacokinetics of Ferric Maltol in Inflammatory Bowel Disease Patients with Iron Deficiency.
    Bokemeyer B; Krummenerl A; Maaser C; Howaldt S; Mroß M; Mallard N
    Eur J Drug Metab Pharmacokinet; 2017 Apr; 42(2):229-238. PubMed ID: 27101422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TREATMENT OF ANEMIA AND IMPROVEMENT OF QUALITY OF LIFE AMONG PATIENTS WITH CROHN'S DISEASE: experience using ferric carboxymaltose.
    Sobrado CW; Cançado RD; Sobrado LF; Frugis MO; Sobrado MF
    Arq Gastroenterol; 2015 Dec; 52(4):255-9. PubMed ID: 26840464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Iron replacement in hemodialysis patients with a normal serum ferritin level].
    Riedel MK; Morgenstern T
    Dtsch Med Wochenschr; 2004 Sep; 129(36):1849-53. PubMed ID: 15368155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ferric maltol is effective in correcting iron deficiency anemia in patients with inflammatory bowel disease: results from a phase-3 clinical trial program.
    Gasche C; Ahmad T; Tulassay Z; Baumgart DC; Bokemeyer B; Büning C; Howaldt S; Stallmach A;
    Inflamm Bowel Dis; 2015 Mar; 21(3):579-88. PubMed ID: 25545376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical significance of C-reactive protein levels in predicting responsiveness to iron therapy in patients with inflammatory bowel disease and iron deficiency anemia.
    Iqbal T; Stein J; Sharma N; Kulnigg-Dabsch S; Vel S; Gasche C
    Dig Dis Sci; 2015 May; 60(5):1375-81. PubMed ID: 25501922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous iron supplementation for the treatment of the anemia of moderate to severe chronic renal failure patients not receiving dialysis.
    Silverberg DS; Iaina A; Peer G; Kaplan E; Levi BA; Frank N; Steinbruch S; Blum M
    Am J Kidney Dis; 1996 Feb; 27(2):234-8. PubMed ID: 8659499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.